Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Phase 1/2 Study of DCC-3116 in Patients With MAPK Pathway Mutant Solid Tumors Ended

2022-501474-19-00 Non-Small Cell Lung Cancer 7
A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Ac… Ended

2024-515258-25-00 advanced solid tumors with KRAS G12C mutation 7
A Phase II, open label, single arm, multicentre study on THOracic Radiotherapy in Extensive Stage SCLC patients submitted to first line CHT-… Ended

2024-517445-13-00 Extended stage small cell lung cancer patients confirme 4
Trial assessing the efficacy of suraparib as first line therapy for patients with metastatic homologous repair-deficient pancreatic cancer Ended

2024-516558-24-00 Pancreatic (PAAD) 4
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan… Ended

2023-506487-13-00 Hormone receptor-positive, her2-negative advanced/metas 5
APRILIAH (Aprogen Phase III Clinical Trial to Compare Efficacy, Safety, and Immunogenicity of AP063 in Subjects with HER2+ Breast Cancer) Ended

2023-506975-83-00 HER2-positive metastatic breast cancer (MBC) and early 5
An open label phase II basket trial exploring the efficacy and safety of the combination of Niraparib and Dostarlimab in patients with DNA r… Ended

2024-514855-13-00 DNA repair-deficient or platinum-sensitive solid tumors 4
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Partici… Ended

2024-512586-13-00 Non-Hodgkin's Lymphoma 1
Pembrolizumab Alone versUs pembrolizumab-chemotherapy in first LInE NSCLC (PAULIEN) Ended

2024-516581-11-00 Advanced stage NSCLC 5
Precision therapy versus standard therapy in Acute Myeloid Leukaemia and Myelodysplastic syndrome in elderly (PALM) – a phase II randomized … Ended

2023-509092-16-00 Chronic myelomonocyte leukemia 4
A Phase 2 Study of Tremelimumab (Day 1 only), Durvalumab (MEDI4736) and Trans-arterial catheter chemoembolization (TACE)in patients with adv… Ended

2023-510117-26-00 Advanced Hepatocellular Carcinoma (HCC) 4
Study to Assess the Safety, Tolerability and Efficacy of Lurbinectedin and Dostarlimab treatment in patients with endometrial cancer after d… Ended

2023-508583-30-00 Advanced/Recurrent Endometrial Cancer Patients with Dis 9
First-in-human (FIH) Study of DS-1471a in Subjects with Advanced Solid Tumors Ended

2024-517984-21-00 Advanced Solid Tumors 1
C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors Ended

2024-517988-23-00 KRAS mutated advanced solid tumors 1
Role of Hydroxychloroquine in therapeutic strategy of Head and Neck cancer and Nonsmall cell lung cancer Ended

2024-516189-12-00 Patients affected by Resectable Head and Neck (HN) canc 4
Electrochemotherapy as a first line treatment in recurrent squamous cell carcinoma of the oral cavity and oropharynx: a randomized controlle… Ended

2025-520735-16-00 CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX 4
Phase 1/2 Study of Belzutifan Plus Palbociclib Versus Belzutifan in Advanced Renal Cell Carcinoma (RCC) Ended

2023-504963-17-00 Advanced ccRCC 9
NXP800 in subjects with Ovarian Cancer Ended

2023-509150-64-00 Platinum-resistant, ARID1a-mutated ovarian, fallopian t 1
A study to investigate the safety, tolerability, pharmacokinetics (PK), and preliminary anticancer activity of GSK4524101 alone or with nira… Ended

2024-520197-36-00 Neoplasms 7
A trial to find out how well CVHNLC works at different dose levels and how safe it is in combination with pembrolizumab in patients with lun… Ended

2024-519651-28-00 metastatic squamous non-small cell lung cancer 1
A clinical study evaluating efficacy and safety of inupadenant in combination with carboplatin and pemetrexed in adults with metastatic nons… Ended

2024-515393-27-00 Nonsquamous non-small cell lung cancer 4
A phase I study of [177Lu]Lu-EVS459 in patients with ovarian and lung cancers Ended

2023-507674-41-00 Advanced high-grade serous ovarian cancer (OC) 1
MK-1200 for Advanced Solid Tumors Ended

2023-508684-68-00 Advanced solid tumor 9
A Phase II study evaluating efficacy of KTE-X19 CAR-T cell therapy in Relapsed or Refractory Mantle-Cell Lymphoma achieving a partial respon… Expired

2022-502907-31-00 Relapsed or Refractory Mantle-Cell Lymphoma 4 2023-12-28